Sallent, Spain

Anna-Maria Pujol-altarriba

This inventor holds 1 USPTO granted patent. Top assignees: Esteve Pharmaceuticals, S.a., Universität Autonoma De Barcelona. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna-Maria Pujol-altarriba. Retrieved from https://idiyas.com/inventor/anna-maria-pujol-altarriba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anna-Maria Pujol-altarriba

Introduction

Anna-Maria Pujol-altarriba is a notable inventor based in Sallent, Spain. She has made significant contributions to the field of biomedical research, particularly in the study of mucopolysaccharidoses. Her work has implications for understanding and treating rare genetic disorders.

Latest Patents

One of her key patents is titled "Animal model of mucopolysaccharidoses type IVA." This invention provides a new animal model for mucopolysaccharidosis type IVA, also known as Morquio A syndrome. The patent outlines methods for generating this animal model and explores its various uses in research and treatment.

Career Highlights

Throughout her career, Anna-Maria has worked with esteemed organizations such as Esteve Pharmaceuticals, S.A. and Universitat Autònoma de Barcelona. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Maria-Fátima Bosch-Tubert and Joan Bertolín-Gálvez. Their collaborative efforts have further advanced the understanding of mucopolysaccharidoses and related conditions.

Conclusion

Anna-Maria Pujol-altarriba's innovative work in developing an animal model for mucopolysaccharidosis type IVA highlights her significant contributions to biomedical research. Her patents and collaborations continue to pave the way for advancements in the treatment of genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…